Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Top 5 Pharmaceuticals Paying Excellent Dividends
Seeking Alpha
Sun, 03/27/11 - 12:10 pm
Tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer
Sanofi Profiles Zalicus Drug Today, a Positive Sign for Investors
Seeking Alpha
Thu, 03/24/11 - 09:22 am
Tags:
Sanofi, Zalicus, Amgen, Novartis, ophthalmology, Prednisporin
What Biotech Wants From Big Pharma Partners: Survey Says!?
InVivo
Wed, 03/23/11 - 10:29 am
Tags:
Big Pharma, biotech, Roche, Merck, GSK, Novartis, Pfizer, Eli Lilly
Novartis must wait longer for FDA lung drug decision
Reuters
Wed, 03/23/11 - 09:38 am
Tags:
FDA, COPD, Novartis, QAB149
Failure of Sanofi, Merck Animal-Health Merger May Trigger Deals
Bloomberg
Tue, 03/22/11 - 10:12 pm
Tags:
animal health, Merck, Sanofi, M&A, Novartis, Bayer
Pharmas in the Doghouse
Motley Fool
Tue, 03/22/11 - 10:06 pm
Tags:
Merck, Sanofi, Pfizer, Genzyme, Novartis, Eli Lilly, JNJ
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tue, 03/22/11 - 11:07 am
Tags:
Novartis, Gilenya, MS, multiple sclerosis, Teva Pharmaceuticals, Biogen Idec, Roche
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
Tags:
ASCO, Medivation, Exelixis, Dendreon, Bristol-Myers Squibb, Roche, Curis, Celgene, Sanofi, Ariad Pharmaceuticals, Merck, Incyte, Novartis, YM BioSciences, Pfizer, Aveo Pharmaceutical, ONYX Pharmaceuticals, Amgen, Synta, Vical, Oxigene, Cell Therapeutics, Oncothyreon
Novartis gets EU approval for oral MS drug
Yahoo/AP
Mon, 03/21/11 - 11:19 am
Tags:
Europe, MS, Novartis, multiple sclerosis
Meet the Cash Kings of Pharma
Motley Fool
Thu, 03/17/11 - 06:20 pm
Tags:
Novartis, Sanofi, Bristol-Myers Squibb
FDA To Novartis: Ciba Vision Needs An Eye Exam
Pharmalot
Wed, 03/16/11 - 10:51 am
Tags:
FDA, Novartis, CIBA Vision
Novartis maps out a blockbuster future for INC424
Fierce Biotech
Wed, 03/16/11 - 09:21 am
Tags:
Novartis, INC424, Incyte, JAK inhibitors, ruxolitinib, myelofibrosis
Extending the Competition in Parkinson's Disease
Motley Fool
Wed, 03/16/11 - 09:17 am
Tags:
Parkinson's Disease, Impax, Merck, Novartis, Pfizer, GSK
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tue, 03/15/11 - 12:31 pm
Tags:
Alzheimer's disease, Razadyne, Nivalin, Ortho-McNeil-Janssen, Exelon, Novartis, Aricept, Eisai, Pfizer, Namenda, Merz, Forest Labs, Eli Lilly, Elan, JNJ, Roche, MorphoSys
Novartis Has Largest Japan Exposure Among Big Pharma
Barron's
Tue, 03/15/11 - 11:08 am
Tags:
Novartis, Japan, Pfizer, Merck, Eli Lilly, GSK, Bristol-Myers Squibb, AstraZeneca, Sanofi
Incyte cancer drug meets goal in Europe study
Yahoo/AP
Tue, 03/15/11 - 10:03 am
Tags:
Incyte, Europe, ruxolitinib, Novartis
Who Will Win the Hepatitis C Market?
Seeking Alpha
Mon, 03/14/11 - 10:44 am
Tags:
hepatitis C, Gilead Sciences, Merck, Bristol-Myers Squibb, Novartis, Pfizer, Vertex Pharmaceuticals, Pharmasset
Theravance Attractive After Novartis' Fumble
Minyanville
Wed, 03/9/11 - 02:25 pm
Tags:
Novartis, Theravance, GSK, COPD, Relovair
Novartis Lung Drug Gets Mixed Verdict
WSJ Online
Wed, 03/9/11 - 10:16 am
Tags:
FDA, COPD, Novartis, indacaterol
Morphosys' Growth Story Remains Intact
Seeking Alpha
Mon, 03/7/11 - 11:42 am
Tags:
MorphoSys, Immunogen, Micromet, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.